By Professor Glenda Halliday

Journal articles

Halliday GM; Bock VL; Moloney FJ; Lyons JG, 2009, 'SWI/SNF: A chromatin-remodelling complex with a role in carcinogenesis', International Journal of Biochemistry and Cell Biology, 41, pp. 725 - 728, http://dx.doi.org/10.1016/j.biocel.2008.04.026

Moloney FJ; Lyons JG; Bock VL; Huang XX; Bugeja MJ; Halliday GM, 2009, 'Hotspot mutation of Brahma in non-melanoma skin cancer', Journal of Investigative Dermatology, 129, pp. 1012 - 1015, http://dx.doi.org/10.1038/jid.2008.319

Halliday GM; King A; McCann H, 2009, '118. Impact of changes in the consensus diagnostic criteria for dementia with lewy bodies', Journal of Clinical Neuroscience, 16, pp. 466 - 467, http://dx.doi.org/10.1016/j.jocn.2008.07.017

Mehta P; Klein C; Proos A; Manwaring N; Vandebona H; Rowe DB; Halliday GM; Sue CM, 2009, '31. Analysis of PINK1 and PARKIN gene mutations in patients with Parkinson’s disease in the Australian community', Journal of Clinical Neuroscience, 16, pp. 1535 - 1535, http://dx.doi.org/10.1016/j.jocn.2009.07.056

Sachdev PS; Lammel A; Trollor JN; Lee T; Wright MJ; Ames D; Wen W; Martin NG; Brodaty H; Schofield PR; Lammel A; Lux O; Halliday G; Kumfor F; Broe G; Schofield P, 2009, 'A comprehensive neuropsychiatric study of elderly twins: the older australian twin study', Twin research and human genetics, 12, pp. 573 - 582, http://dx.doi.org/10.1375/twin.12.6.573

, 2009, 'Abstracts of the 110th Meeting of the British Neuropathological Society. January 7-9, 2009. London, United Kingdom.', Neuropathol Appl Neurobiol, 35 Suppl 1, pp. 1 - 38, http://dx.doi.org/10.1111/j.1365-2990.2008.01003.x

Double KL; Rowe DB; Carew-Jones F; Hayes M; Chan DK; Blackie J; Corbett AJ; Joffe R; Fung VS; Morris JG; Riederer P; Gerlach M; Halliday GM, 2009, 'Anti-melanin antibodies are increased in sera in Parkinson`s disease', Experimental Neurology, 217, pp. 297 - 301

Woodhouse A; Shepherd CE; Sokolova A; Carroll V; King AE; Halliday GM; Dickson TC; Vickers J, 2009, 'Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease', ACTA Neuropathologica, 117, pp. 19 - 29

Song YC; Halliday GM; Holton J; Lashley T; Osullivan S; Mccann H; Lees A; Ozawa T; Williams DR; Lockhart PJ; Revesz T, 2009, 'Degeneration in different parkinsonian syndromes relates to astrocyte type and astrocyte protein expression', Journal of Neuropathology and Experimental Neurology, 68, pp. 1073 - 1083

Sutherland GT; Halliday GM; Silburn PA; Mastaglia F; Rowe DB; Boyle R; O Sullivan JD; Ly T; Wilton SD; Mellick GD, 2009, 'Do polymorphisms in the familial parkinsonism genes contribute to risk for sporadic Parkinson`s disease?', Movement Disorders, 24, pp. 833 - 838

Piguet O; Halliday GM; Creasey H; Broe T; Kril J, 2009, 'Frontotemporal dementia and dementia with Lewy bodies in a case-control study of Alzheimer's disease', International Psychogeriatrics, 21, pp. 688 - 695

Brooks D; Halliday GM, 2009, 'Intralaminar nuclei of the thalamus in Lewy body diseases', Brain Research Bulletin, 78, pp. 97 - 104

Mehta P; Mellick GD; Rowe DB; Halliday GM; Jones MM; Manwaring N; Vandebona H; Silbum P; Wang JJ; Mitchell P; Sue C, 2009, 'Mitochondrial DNA Haplogroups J and K are not Protective for Parkinson`s Disease in the Australian Community', Movement Disorders, 24, pp. 290 - 292

Sokolova A; Hill MD; Rahimi F; Warden LA; Halliday GM; Shepherd CE, 2009, 'Monocytle chemoattractant protein-1 plays a dominant role in the chronic inflammation observed in Alzheimer's disease', Brain Pathology, 19, pp. 392 - 398

Dickson D; Braak H; Duda J; Duyckaerts C; Gasser T; Halliday GM; Hardy J; Leverenz J; Del Tredici K; Wszolek Z; Litvan I, 2009, 'Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria', , 8, pp. 1150 - 1157

Halliday GM; Herrero M; Murphy K; Mccann H; Ros-Bernal F; Barcia C; Mori H; Blesa F; Obeso J, 2009, 'No Lewy pathology in monkeys with over 10 years of severe MPTP parkinsonism', Movement Disorders, 24, pp. 1519 - 1545

Mackenzie IR; Neumann M; Bigio E; Cairns NJ; Alafuzoff I; Kril J; Kovacs G; Ghetti B; Halliday GM; Holm I; Ince PG; Kamphorst W; Revesz T; Rozemuller A; Kumar-Singh S; Akiyama H; Baborie A; Spina S; Dickson DW; Trojanowski JQ; Mann DM, 2009, 'Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: Consensus recommendations', ACTA Neuropathologica, 117, pp. 15 - 18

Shepherd CE; Gregory G; Warden L; Halliday G, 2009, 'O2‐03‐02: Oligomeric Aβ40 species accumulate in the toxic plaques in Alzheimer's disease', Alzheimer's & Dementia, 5, http://dx.doi.org/10.1016/j.jalz.2009.05.335

Monoranu C; Apfelbacher M; Grunblatt E; Puppe B; Alafuzoff I; Ferrer I; Al-Saraj S; Keyvani K; Schmitt A; Falkai P; Schittenhelm J; Halliday GM; Kril J; Harper C; Mclean C; Riederer P; Roggendorf W, 2009, 'pH measurement as quality control on human post mortem brain tissue: A study of the BrainNet Europe consortium', Neuropathology and Applied Neurobiology, 35, pp. 329 - 337

Van Eersel J; Bi M; Ke Y; Hodges JR; Xuereb J; Gregory GC; Halliday GM; Gotz J; Kril J; Ittner L, 2009, 'Phosphorylation of soluble tau differs in Pick's disease and Alzheimer's disease brains', Journal of Neural Transmission, 116, pp. 1243 - 1251

Truong L; Brooks D; Amaral F; Henderson J; Halliday GM, 2009, 'Relative preservation of thalamic centromedian nucleus in Parkinsonian patients with dystonia', Movement Disorders, 24, pp. 2128 - 2135

Halliday GM, 2009, 'Thalamic changes in Parkinson's disease', Parkinsonism and Related Disorders, 15S3, pp. S152 - S155

Davies R; Halliday GM; Xuereb J; Kril J; Hodges JR, 2009, 'The neural basis of semantic memory: Evidence from semantic dementia', Neurobiology of Aging, 30, pp. 2043 - 2052

Grunblatt E; Monoranu C; Apfelbacher M; Keller D; Michel T; Alafuzoff I; Ferrer I; Al-Saraj S; Keyvani K; Schmitt A; Falkai P; Schittenhelm J; Mclean C; Halliday GM; Harper C; Deckert J; Roggendorf W; Riederer P, 2009, 'Tryptophan is a marker of human postmortem brain tissue quality', Journal of Neurochemistry, 110, pp. 1400 - 1408

Mevawalla N; Fung VS; Morris JC; Halliday GM, 2009, 'Unilateral rest tremor in vascular Parkinsonism associated with a contralateral lesion of the locus coeruleus', Movement Disorders, 24, pp. 1242 - 1244

Shepherd CE; Mccann H; Halliday GM, 2009, 'Variations in the neuropathology of familial Alzheimer's disease', ACTA Neuropathologica, 118, pp. 37 - 52

Piguet O; Double KL; Kril J; Harasty JA; Macdonald V; Mcritchie DA; Halliday GM, 2009, 'White matter loss in healthy ageing: A postmortem analysis', Neurobiology of Aging, 30, pp. 1288 - 1295

Hersey P; Halliday GM; Farrelly ML; DeSilva C; Lett M; Menzies SW, 2008, 'Phase I/II study of treatment with matured dendritic cells with or without low dose IL-2 in patients with disseminated melanoma', CANCER IMMUNOLOGY IMMUNOTHERAPY, 57, pp. 1039 - 1051, http://dx.doi.org/10.1007/s00262-007-0435-8

Halliday GM; Lyons JG, 2008, 'Inflammatory doses of UV may not be necessary for skin carcinogenesis', Photochemistry and Photobiology, 84, pp. 272 - 283, http://dx.doi.org/10.1111/j.1751-1097.2007.00247.x

Huang Y; Halliday GM; Mastaglia FL; Rowe DB; Sue CM, 2008, '410: Autosomal dominant late-onset Parkinson’s disease due to a novel A1442P mutation in the LRRK2 gene', Journal of Clinical Neuroscience, 15, pp. 344 - 345, http://dx.doi.org/10.1016/j.jocn.2007.07.023

Loy CT; Brooks BS; Taddei K; Patton A; McLean C; Halliday GM; Martins R; Kwok JB; Schofield PR, 2008, '417: A consanguineous family with Frontotemporal Dementia/Motor Neuron Disease', Journal of Clinical Neuroscience, 15, pp. 347 - 347, http://dx.doi.org/10.1016/j.jocn.2007.07.030

Halliday GM, 2008, 'Clarifying the pathological progression of Parkinson`s disease', ACTA Neuropathologica, 115, pp. 377 - 378, http://dx.doi.org/10.1007/s00401-008-0353-7

Murphy KE; Karaconji T; Hardman CD; Halliday GM, 2008, 'Excessive dopamine neuron loss in progressive supranuclear palsy', Movement Disorders, 23, pp. 607 - 610, http://dx.doi.org/10.1002/mds.21907

Sutherland GR; Mellick GD; Newman J; Double KL; Stevens J; Lee L; Rowe DB; Silburn PA; Halliday GM, 2008, 'Haplotype analysis of the IGF2-INS-TH gene cluster in Parkinson`s disease', American Journal of Medical Genetics Part B - Neuropsychiatric Genetics, 147B, pp. 495 - 499, http://dx.doi.org/10.1002/ajmg.b.30633

Halliday GM; Mccann H, 2008, 'Human-based studies on alpha-synuclein deposition and relationship to Parkinson`s disease symptoms', Experimental Neurology, 209, pp. 12 - 21, http://dx.doi.org/10.1016/j.expneurol.2007.07.006

Huang Y; Song YC; Murphy KE; Holton J; Lashley T; Revesz T; Gai WP; Halliday GM, 2008, 'LRRK2 and parkin immuoreactivity in multiple system atrophy inclusions', ACTA Neuropathologica, 116, pp. 639 - 646

Young VG; Halliday GM; Kril J, 2008, 'Neuropathologic correlates of white matter hyperintensities', Neurology, 71, pp. 804 - 811

Elliott DA; Kim WS; Halliday GM; Garner B, 2008, 'P3‐294: Post‐translational modifications of apolipoprotein‐e in the human brain', Alzheimer's & Dementia, 4, http://dx.doi.org/10.1016/j.jalz.2008.05.1862

Luty A; Kwok JB; Thompson E; Blumbergs PC; Brooks WS; Loy CT; Dobson-Stone C; Panegyres P; Hecker J; Nicholson GA; Halliday GM; Schofield PR, 2008, 'Pedigree with frontotemporal lobar degeneration - motor neuron disease and Tar DNA binding protein-43 positive neuropathology: genetic linkage to chromosome 9', BMC NEUROLOGY, 8

Double KL; Dedov V; Fedorow HS; Kettle E; Halliday GM; Garner B; Brunk U, 2008, 'The comparative biology of neuromelanin and lipofuscin in the human brain', CMLS - Cellular and Molecular Life Sciences, 65, pp. 1669 - 1682, http://dx.doi.org/10.1007/s00018-008-7581-9

Halliday GM; Hely MA; Reid WG; Morris JG, 2008, 'The progression of pathology in longitudinally followed patients with Parkinson`s disease', ACTA Neuropathologica, 115, pp. 409 - 415, http://dx.doi.org/10.1007/s00401-008-0344-8

Hely MA; Reid WG; Adena MA; Halliday GM; Morris JG, 2008, 'The Sydney multicenter study of Parksinon`s disease: The inevitability of dementia at 20 years', Movement Disorders, 23, pp. 837 - 844

Karlstrom H; Brooks WS; Kwok JB; Broe T; Kril J; Mccann H; Halliday GM; Schofield PR, 2008, 'Variable phenotype of Alzheimer's disease with spastic paraparesis', Journal of Neurochemistry, 104, pp. 573 - 583, http://dx.doi.org/10.1111/j.1471-4159.2007.05038.x

Christine Song YJ; Huang Y; Lundvig D; Gai WP; Blumbergs P; Hojrup P; Otzen D; Halliday G; Jensen P, 2007, '1.210 P25alpha relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy', Parkinsonism & Related Disorders, 13, pp. S63 - S63, http://dx.doi.org/10.1016/s1353-8020(08)70483-8

Stevens J; Huang Y; Vandenbona H; Halliday GM; Mellick G; Mastaglia F; Kwok J; Sue CM, 2007, '307: Prevalence of LRRK2 mutations in Australians with Parkinson’s Disease', Journal of Clinical Neuroscience, 14, pp. 1009 - 1010, http://dx.doi.org/10.1016/j.jocn.2007.02.013

Piguet O; Bennett HP; Waite LM; Kril JJ; Creasey H; Broe GA; Halliday GM, 2007, '619: Preserved cognition and functional independence after a large right PCA infarct: longitudinal clinical and neuropathological findings', Journal of Clinical Neuroscience, 14, pp. 1023 - 1024, http://dx.doi.org/10.1016/j.jocn.2007.02.050

Schofield EC; McCredie RL; Halliday GM; Cordato NJ, 2007, '621: Changes in regional cerebral blood flow relate to cognitive and behavioural symptoms in progressive supranuclear palsy', Journal of Clinical Neuroscience, 14, pp. 1024 - 1025, http://dx.doi.org/10.1016/j.jocn.2007.02.052

Brooks DJ; Harding AJ; Halliday GM, 2007, '622: Visual hallucinations and fluctuating consciousness relate to pathology of the limbic thalamus in Lewy body dementias', Journal of Clinical Neuroscience, 14, pp. 1025 - 1025, http://dx.doi.org/10.1016/j.jocn.2007.02.053

Sutherland GT; Sue C; Mellick GD; Lee L; Rowe DB; Silburn PA; Halliday GM, 2007, '643: Promotor polymorphisms lowering parkin expression reduce the age of onset of Parkinson’s disease', Journal of Clinical Neuroscience, 14, pp. 1033 - 1033, http://dx.doi.org/10.1016/j.jocn.2007.02.074

Sutherland GT; Mellick GD; Sue C; Chan DK; Rowe DB; Silburn PA; Halliday GM, 2007, 'A functional polymorphism in the parkin gene promoter affects the age of onset of Parkinson`s disease', Neuroscience Letters, 414, pp. 170 - 173

Back to profile page